rHPIV3cp45

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Paramyxoviridae InfectionsVirus Diseases

Phase 1

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

CompletedNCT00308412

National Institute of Allergy and Infectious Diseases (NIAID)Paramyxoviridae Infections, Virus Diseases

Start: 2006-06-30End: 2010-04-30Updated: 2010-07-16

Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children

CompletedNCT01021397

National Institute of Allergy and Infectious Diseases (NIAID)Paramyxoviridae Infections, Virus Diseases

Start: 2009-11-30End: 2011-12-31Updated: 2013-01-03